News
Doctors for America is trying to join the suit to ensure women can get abortions when their lives or health depend on the ...
Pennsylvania State Sen. Tim Kearney and State Rep. Lisa Borowski introduced legislation addressing private equity and ...
The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of ...
Reproductive-rights advocates are pushing back against the review of the abortion medication mifepristone ordered by Health ...
Though unnamed in the HHS announcement, the legal group involved ... Hospital was requiring religious staff to assist in abortions. The hospital had changed its policy in late 2024, requiring ...
“I have asked Marty Makary, who is the director at FDA, to do a complete review and report back,” the HHS secretary revealed ... “largest-known” on the abortion pill – analyzed insurance ...
Nationwide, more than four in five people who use Title X's services are women, according to HHS. Federal law prohibits clinics from using Title X money to pay for abortions. However, HHS ...
As HHS secretary, Kennedy has some power over abortion access. Anti-abortion groups are ramping up pressure to make sure their policy priorities are enacted, starting with mifepristone ...
Secretary of Health and Human Services (HHS) Robert F. Kennedy Jr. reiterated that he plans to investigate safety concerns related to the abortion pill mifepristone during an interview on Fox ...
Abortion is one of the many health issues that falls within the purview of Kennedy’s mandate as secretary of HHS. As head of the agency, the positions he takes will have life and death ...
Their concerns mounted after Trump named Robert F. Kennedy Jr., a longtime supporter of abortion rights, to lead HHS -- and then as he signed a slew of Day 1 executive orders that said nothing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results